Invention Grant
US08088782B2 Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline difumarate form A
有权
4-（3-氯-2-氟苯胺基）-7甲氧基-6 - {[1-（N-甲基氨基甲酰基甲基）哌啶-4-基]氧基}喹唑啉二磺酸甲酯形式A
![Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline difumarate form A](/docs/US/2012-01-03/US08088782B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline difumarate form A
- Patent Title (中): 4-（3-氯-2-氟苯胺基）-7甲氧基-6 - {[1-（N-甲基氨基甲酰基甲基）哌啶-4-基]氧基}喹唑啉二磺酸甲酯形式A
-
Application No.: US12463624Application Date: 2009-05-11
-
Publication No.: US08088782B2Publication Date: 2012-01-03
- Inventor: Andrew Hornby Dobson
- Applicant: Andrew Hornby Dobson
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Main IPC: A61K31/517
- IPC: A61K31/517
![Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline difumarate form A](/abs-image/US/2012/01/03/US08088782B2/abs.jpg.150x150.jpg)
Abstract:
4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline difumarate, pharmaceutical compositions containing the difumarate, the use of the difumarate in the treatment of hyperproliferative disorders such as cancer and processes for the manufacture of the difumarate are described.
Public/Granted literature
- US20090286982A1 NOVEL SALT-554 Public/Granted day:2009-11-19
Information query
IPC分类:
